Yasuo Hara Selected Research

Breast Neoplasms (Breast Cancer)

11/2007	Expression of estrogen receptor beta wild-type and its variant ERbetacx/beta2 is correlated with better prognosis in breast cancer.
6/2006	NCOR1 mRNA is an independent prognostic factor for breast cancer.
1/2006	Clinical usefulness of oral combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR) and cyclophosphamide for metastatic breast cancer.
11/2005	Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast*.
12/2003	Biweekly paclitaxel in patients with metastatic breast cancer.
10/2003	p33(ING1b) stimulates the transcriptional activity of the estrogen receptor alpha via its activation function (AF) 2 domain.
1/2003	Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer.
1/2003	Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuo Hara Research Topics

Disease

11	Neoplasms (Cancer) 08/2014 - 07/2002
8	Breast Neoplasms (Breast Cancer) 11/2007 - 01/2003
2	Carcinogenesis 11/2005 - 07/2002
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2003 - 07/2002
2	Ductal Carcinoma 01/2003 - 07/2002
1	Parkinson Disease (Parkinson's Disease) 01/2016
1	Ovarian Teratoma 09/2007
1	Encephalitis (Encephalitis, Rasmussen) 09/2007
1	Carcinoma (Carcinomatosis) 11/2005
1	Neoplasm Metastasis (Metastasis) 01/2003

Drug/Important Bio-Agent (IBA)

5	Messenger RNA (mRNA)IBA 11/2007 - 01/2003
3	Proteins (Proteins, Gene)FDA Link 11/2007 - 08/2002
3	Estrogens (Estrogen)FDA Link 11/2005 - 07/2002
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2007 - 11/2005
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2007 - 01/2006
2	Estrogen Receptor alphaIBA 06/2006 - 11/2005
2	Aromatase (CYP19)IBA 01/2003 - 07/2002
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2016
1	EtanidazoleIBA 08/2014
1	Estrogen Receptor betaIBA 11/2007
1	Intravenous Immunoglobulins (IVIG)FDA Link 09/2007
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2007
1	AutoantibodiesIBA 09/2007
1	Nuclear Receptor Co-Repressor 1IBA 06/2006
1	ProdrugsIBA 01/2006
1	Thymidine PhosphorylaseIBA 01/2006
1	doxifluridineIBA 01/2006
1	Fluorouracil (Carac)FDA LinkGeneric 01/2006
1	ChromatinIBA 11/2005
1	Histones (Histone)IBA 11/2005
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2003
1	Histone Deacetylases (Histone Deacetylase)IBA 10/2003
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 10/2003
1	Codon (Codons)IBA 03/2003
1	Estrogen ReceptorsIBA 01/2003
1	DNA (Deoxyribonucleic Acid)IBA 01/2003
1	Aromatase InhibitorsIBA 07/2002

Therapy/Procedure

1	Immunotherapy 09/2007
1	Plasma Exchange 09/2007
1	Combination Drug Therapy (Combination Chemotherapy) 01/2006
1	Therapeutics 07/2002